However, this trend toward self-medication or supplemental therapy comes with a set of unique risks for the geriatric population. Dr. Han, speaking from his perspective as a geriatrician, expressed concern about the potential for adverse effects. He noted that while more of his patients are expressing interest in cannabis to treat their health symptoms, the substance can complicate the management of complex chronic diseases. Aging brings about physiological changes—such as a slower metabolism, changes in body composition, and decreased organ function—that can make older adults much more sensitive to psychoactive substances than younger users. There is also the significant risk of drug-to-drug interactions, as many seniors are already taking a regimen of several prescription medications.
The study authors also pointed out a "cohort effect" that likely contributes to these rising numbers. The generation currently entering the 65-and-older bracket—the Baby Boomers—came of age during a period when marijuana was more culturally visible than it was for the generations that preceded them. As these individuals age, they may be carrying their previous experiences with cannabis into their later years, or they may be more open to returning to the drug now that legal and social barriers have been lowered. In essence, the increase is partly driven by people who were already comfortable with cannabis "aging into" the demographic studied.
Regardless of the underlying reasons, the researchers are calling for a proactive response from the medical community. They recommend that clinicians incorporate routine screening for cannabis use into their evaluations of older patients. This is not necessarily for the purpose of discouragement, but rather to ensure that patients are educated on the potential risks and how cannabis might interact with their existing health conditions and medications. Education is paramount, as many seniors may operate under the assumption that "natural" or "legal" necessarily means "risk-free," a misconception that can lead to complications in a population already vulnerable to falls, cognitive impairment, and cardiovascular stress.
The research, which also involved co-authors Kevin H. Yang of UC San Diego and Charles Cleland of NYU Grossman School of Medicine, was supported by several grants from the National Institute on Drug Abuse (NIDA) and the UC San Diego Sam and Rose Stein Institute for Research on Aging. As the legal landscape continues to shift and more states consider recreational and medical legalization, the researchers expect that these numbers will only continue to rise. The study serves as a vital reminder that the conversation surrounding cannabis in America is no longer just about youth culture or criminal justice reform; it is increasingly a conversation about geriatric care, chronic disease management, and the evolving health needs of an aging nation.
